
Childhood type 1 diabetes screening is effective and could prevent thousands of emergency diagnoses
Recruitment for next phase of the trial called ELSA 2 launches, expanding screening to include children aged 2-17
- Published: 20 January 2026
Filter
70 results were found based on your search term

Recruitment for next phase of the trial called ELSA 2 launches, expanding screening to include children aged 2-17

Professors Patricia Lalor and Alex Richter will work alongside Professor Andrew Filer to further strengthen the BRC’s leadership team.

The new recipients of the University’s fellowship scheme will receive support to develop independent research.

Clinical Immunology Services and PHTA leaders were honoured at the 2025 Innovation Awards, with Professor Alex Richter named Female Innovator of the Year.

The trial will investigate whether a new medical device, Carbalive, can slow disease progression of a rare liver disease

The BactiVac Network secures major funding to advance its mission of accelerating vaccine development against bacterial infections affecting LMICs.

Birmingham researchers will join 2025 Nobel Prize winner Professor Shimon Sakaguchi in a research programme to transform treatment of autoimmune diseases.

Researchers discover a circulating protein responsible for disabling the body’s immune response to tumours; bexmarilimab blocks its release